Literature DB >> 22731728

Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms.

Lila G Glotfelty1, Gail A Hecht.   

Abstract

Enteropathogenic E. coli (EPEC) infection is a major cause of infantile diarrhea in the developing world. Using a type-three secretion system, bacterial effector proteins are transferred to the host cell cytosol where they affect multiple physiological functions, ultimately leading to diarrheal disease. Disruption of intestinal epithelial cell tight junctions is a major consequence of EPEC infection and is mediated by multiple effector proteins, among them EspG1 and its homologue EspG2. EspG1/G2 contribute to loss of barrier function via an undefined mechanism that may be linked to their disruption of microtubule networks. Recently new investigations have identified additional roles for EspG. Sequestration of active ADP-ribosylating factor (ARF) proteins and promotion of p21-activated kinase (PAK) activity as well as inhibition of Golgi-mediated protein secretion have all been linked to EspG. In this review, we examine the functions of EspG1/G2 and discuss potential mechanisms of EspG-mediated tight junction disruption.
© 2012 New York Academy of Sciences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22731728      PMCID: PMC4063556          DOI: 10.1111/j.1749-6632.2012.06563.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  86 in total

1.  RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin.

Authors:  Matthias Bruewer; Ann M Hopkins; Michael E Hobert; Asma Nusrat; James L Madara
Journal:  Am J Physiol Cell Physiol       Date:  2004-03-24       Impact factor: 4.249

2.  Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.

Authors:  Paul Dean; Brendan Kenny
Journal:  Mol Microbiol       Date:  2004-11       Impact factor: 3.501

3.  The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity.

Authors:  Kim Hodges; Neal M Alto; K Ramaswamy; Pradeep K Dudeja; Gail Hecht
Journal:  Cell Microbiol       Date:  2008-04-21       Impact factor: 3.715

4.  Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli.

Authors:  C Wolff; I Nisan; E Hanski; G Frankel; I Rosenshine
Journal:  Mol Microbiol       Date:  1998-04       Impact factor: 3.501

5.  Cloning of the RDEC-1 locus of enterocyte effacement (LEE) and functional analysis of the phenotype on HEp-2 cells.

Authors:  D K Karaolis; T K McDaniel; J B Kaper; E C Boedeker
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

6.  Role of microtubules in the distribution of the Golgi apparatus: effect of taxol and microinjected anti-alpha-tubulin antibodies.

Authors:  J Wehland; M Henkart; R Klausner; I V Sandoval
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

7.  Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease.

Authors:  Stephanie A Blair; Sunanda V Kane; Daniel R Clayburgh; Jerrold R Turner
Journal:  Lab Invest       Date:  2006-02       Impact factor: 5.662

8.  STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction.

Authors:  Michael J Rosen; Mark R Frey; M Kay Washington; Rupesh Chaturvedi; Lindsay A Kuhnhein; Poojitha Matta; Frank L Revetta; Keith T Wilson; D Brent Polk
Journal:  Inflamm Bowel Dis       Date:  2011-02-09       Impact factor: 5.325

9.  A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease.

Authors:  Yevgeny Zolotarevsky; Gail Hecht; Athanasia Koutsouris; Deborah E Gonzalez; Cliff Quan; Jeffrey Tom; Randall J Mrsny; Jerrold R Turner
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

10.  Structural and functional regulation of tight junctions by RhoA and Rac1 small GTPases.

Authors:  T S Jou; E E Schneeberger; W J Nelson
Journal:  J Cell Biol       Date:  1998-07-13       Impact factor: 10.539

View more
  11 in total

1.  Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis.

Authors:  Anand Prakash Singh; Saima Aijaz
Journal:  Bioengineered       Date:  2015-10-02       Impact factor: 3.269

2.  Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.

Authors:  Tiha M Long; Shahista Nisa; Michael S Donnenberg; Bret A Hassel
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

3.  Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption.

Authors:  Vijay Morampudi; Franziska A Graef; Martin Stahl; Udit Dalwadi; Victoria S Conlin; Tina Huang; Bruce A Vallance; Hong B Yu; Kevan Jacobson
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 4.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 5.  How Bacteria Subvert Animal Cell Structure and Function.

Authors:  Alyssa Jimenez; Didi Chen; Neal M Alto
Journal:  Annu Rev Cell Dev Biol       Date:  2016-05-04       Impact factor: 13.827

6.  Mechanisms of DRA recycling in intestinal epithelial cells: effect of enteropathogenic E. coli.

Authors:  Tarunmeet Gujral; Anoop Kumar; Shubha Priyamvada; Seema Saksena; Ravinder K Gill; Kim Hodges; Waddah A Alrefai; Gail A Hecht; Pradeep K Dudeja
Journal:  Am J Physiol Cell Physiol       Date:  2015-10-07       Impact factor: 4.249

7.  Republished: tracing PAKs from GI inflammation to cancer.

Authors:  Kyle Dammann; Vineeta Khare; Christoph Gasche
Journal:  Postgrad Med J       Date:  2014-11       Impact factor: 2.401

Review 8.  Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes.

Authors:  Fernando Navarro-Garcia; Antonio Serapio-Palacios; Paul Ugalde-Silva; Gabriela Tapia-Pastrana; Lucia Chavez-Dueñas
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

Review 9.  Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system.

Authors:  Heike Stier; Stephan C Bischoff
Journal:  Clin Exp Gastroenterol       Date:  2016-09-13

10.  Glycomacropeptide Reduces Intestinal Epithelial Cell Barrier Dysfunction and Adhesion of Entero-Hemorrhagic and Entero-Pathogenic Escherichia coli in Vitro.

Authors:  Shane Feeney; Joseph Thomas Ryan; Michelle Kilcoyne; Lokesh Joshi; Rita Hickey
Journal:  Foods       Date:  2017-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.